Holland O B
Drugs. 1986;31 Suppl 4:78-84. doi: 10.2165/00003495-198600314-00010.
In the past, potassium depletion in both non-digitalised patients and in patients without cardiac disease was thought to cause no adverse cardiac effects. However, several studies have now demonstrated a significant incidence of ventricular ectopic activity (VEA) with diuretic-induced hypokalaemia, even in hypertensive patients without overt heart disease. Additional evidence suggests that sudden death may occasionally result from this VEA. Potassium repletion with potassium-sparing diuretics or with potassium chloride supplementation has generally demonstrated a beneficial therapeutic effect in reducing VEA. However, after diuretic therapy occasional patients may have persistent VEA which may result from focal myocardial lesions associated with potassium depletion. In contrast, diuretic therapy in which normokalaemia is maintained has only been associated with a very low occurrence of VEA. Thus, with the preservation of normokalaemia, diuretic therapy for hypertension does not appear to be associated with the significant hazards of VEA.
过去,人们认为非洋地黄化患者和无心脏病患者的钾缺乏不会对心脏产生不良影响。然而,现在有几项研究表明,即使在无明显心脏病的高血压患者中,利尿剂诱发的低钾血症也会导致室性异位活动(VEA)的发生率显著升高。更多证据表明,这种室性异位活动偶尔可能导致猝死。使用保钾利尿剂或补充氯化钾进行补钾,通常已证明在减少室性异位活动方面具有有益的治疗效果。然而,在利尿治疗后,偶尔会有患者出现持续性室性异位活动,这可能是由与钾缺乏相关的局灶性心肌病变引起的。相比之下,维持血钾正常的利尿治疗仅与极低的室性异位活动发生率相关。因此,在维持血钾正常的情况下,高血压的利尿治疗似乎不会带来室性异位活动的重大风险。